Rezultati - Wu‐Chou Su
- Showing 1 - 20 results of 72
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis od Yi-Te Huang, Yaping Chen, Wen-Chih Lin, Wu‐Chou Su, Yuan‐Ting Sun
Izdano 2020Revisão -
6
-
7
-
8
-
9
Sp1 expression regulates lung tumor progression od Tsung‐I Hsu, M-C Wang, S. Y. Chen, Y-M Yeh, Wu‐Chou Su, W-C Chang, Jan‐Jong Hung
Izdano 2011Artigo -
10
Pronounced induction of endoplasmic reticulum stress and tumor suppression by surfactant-free poly (lactic-co-glycolic acid) nanoparticles via modulation of the PI3K signaling path... od Chia Cheng Hou, Tsung‐Lin Tsai, Wen Pin Su, Hsing Pang Hsieh, Chen-Sheng Yeh, Dar Bin Shieh, Wu‐Chou Su
Izdano 2013Artigo -
11
Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and... od Wei-Lun Huang, Hsuan-Heng Yeh, Chien‐Chung Lin, Wu‐Wei Lai, Jang-Yang Chang, Wen-Tsan Chang, Wu‐Chou Su
Izdano 2010Artigo -
12
-
13
-
14
-
15
Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis od Chung‐Ying Lin, Jing-Shiang Hwang, Wen‐Chung Wang, Wu‐Wei Lai, Wu‐Chou Su, Tzu‐Yi Wu, Grace Yao, Jung‐Der Wang
Izdano 2018Artigo -
16
Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy od Helen H.W. Chen, Jiang Yan, Wen-Chung Chen, Macus Tien Kuo, Yu-Hsuan Lai, Wu Wei Lai, Hsiao‐Sheng Liu, Wu‐Chou Su
Izdano 2011Artigo -
17
-
18
Global Oct4 target gene analysis reveals novel downstream <i>PTEN</i> and <i>TNC</i> genes required for drug-resistance and metastasis in lung cancer od Yen-An Tang, Chi-Hsin Chen, H. Sunny Sun, Chun-Pei Cheng, Vincent S. Tseng, Han‐Shui Hsu, Wu‐Chou Su, Wu‐Wei Lai, Yi‐Ching Wang
Izdano 2015Artigo -
19
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer od Andrew H. Ko, Margaret A. Tempero, Y-S Shan, Wu‐Chou Su, Yulin Lin, Elizabeth Dito, A. Ong, Y-W Wang, Chen‐Hao Yeh, L-T. Chen
Izdano 2013Artigo -
20
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer od Po‐Lan Su, Yi‐Lin Wu, Wei-Yuan Chang, Chung‐Liang Ho, Yau‐Lin Tseng, Wu‐Wei Lai, Wu‐Chou Su, Chien‐Chung Lin, Szu‐Chun Yang
Izdano 2018Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cancer
Oncology
Biology
Lung cancer
Genetics
Cancer research
Gene
Epidermal growth factor receptor
Gastroenterology
Adverse effect
Biochemistry
Cell biology
Chemotherapy
Gefitinib
Adenocarcinoma
Clinical endpoint
Clinical trial
Erlotinib
Pathology
Confidence interval
Phases of clinical research
Tyrosine-kinase inhibitor
Surgery
Environmental health
Genotype
Metastasis
Receptor
Response Evaluation Criteria in Solid Tumors